Dr. Lynn Schuchter is program leader of the clinical investigations program at Penn Medicine. Her specialties include melanoma, breast cancer with a emphasis on new approaches to treatment and prevention. Dr. Schuchter is also a member of the College of Physicians and the Association Society of Clinical Oncology.
Penn Medicine's Division of Hematology/Oncology is one of the largest hematology/oncology groups in the country. We are recognized nationally and internationally for our excellence in patient care, research and training. Our physicians care for patients with all types of cancer and benign blood-related disorders, from the most common to the most complex, seeing more than 45,000 outpatient visits annually.
Our faculty members are on the leading edge of cancer and benign hematology research in areas including immunotherapy, the development of molecularly targeted therapies, cancer genetics and complex multidisciplinary care working closely with other oncology disciplines. They are also committed to the education and training of the next generation of medical professionals in these key specialty fields.
The physicians and nurses of Penn Hematology/Oncology provide a comprehensive and integrated approach to patient care. Our patients benefit from a team of experts from varied specialties working together to determine the best treatment plan; all in a patient- and family-centric environment.
But Penn Hematology/Oncology is more than the fact that its physicians are leaders in their fields who ensure the best and most compassionate patient care. They are also keenly aware that every patient is a person with a family and a life before, during and after their illness. Penn's team-based approach to care ensures that every aspect of patient care; medical, physical, emotional and spiritual; gets the proper attention. The division works closely every day with colleagues in other medical and allied specialties, and is an integral component of Penn's Abramson Cancer Center.
Our mission is threefold:
To provide comprehensive and compassionate care to patients and their families.
To conduct basic, translational and clinical research to improve outcomes and develop cures for patients with cancer and blood disorders.
To educate and train the next generation of physicians, researchers and future leaders.
I invite you to browse our website and encourage you to learn more about the many wonderful and exciting programs and initiatives of Penn Medicine's Division of Hematology and Oncology.
Lynn M. Schuchter, MD
Division Chief, Hematology-Oncology
University of Pennsylvania, C. Willard Robinson Professor of Hematology-Oncology
Program Leader: Melanoma Program, Abramson Cancer Center of the University of Pennsylvania